Stocks / NASDAQ / Clarus Therapeutics Holdings Inc.

Clarus Therapeutics Holdings Inc.

Our Opinion

Clarus Therapeutics Holdings Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing to assess a product’s safety profile.

Company Description

Clarus Therapeutics Holdings, Inc., formerly Blue Water Acquisition Corp., is a specialty pharmaceutical company. The Company is focused on the commercialization of JATENZO, an oral T-replacement, or T-replacement therapy (TRT). The Company’s lead product, JATENZO, an androgen indicated for T-replacement therapy to treat adult men with hypogonadism due to certain medical conditions.

Company Website: